They Just Don't Get...
Health Care: Drugs
Lannett Incorporated (LCI: AMEX)
$4.96 -0.09 | -1.78%
02/09/12 - 04:01 PM ET
29.70K / 45.10K
Vol / Avg. Vol:5.00 / 5.05
Open / Prev. Close:4.95 - 5.05
Today's Range:3.41 - 5.95
52 Wk Range:14.25%
Performance YTD:TheStreet Rating:
Portfolios with LCI
- Portfolio NameUser Type
- UserLA
- UserPrimetime300
- Usermyfaves Portfolio 1
- UserBarron's Insider Purchases ...
- UserUner $10
- Usertom Portfolio 1
Latest LCI Headlines from TheStreet
- Lannett Incorporated Stock Upgraded (LCI) 10.28.11 | 07:10 am
- Lannett Incorporated Stock Downgraded (LCI) 09.09.11 | 07:09 am
- Lannett Incorporated Stock Downgraded (LCI) 06.06.11 | 08:06 am
- Lannett Incorporated Stock Upgraded By TheStreet Ratings (LCI) 02.15.11 | 05:02 pm
- FDA Cracks Down On Unapproved Narcotic Painkillers 03.31.09 | 03:03 pm
- Wednesday's Health Winners & Losers 12.12.07 | 03:12 pm
- Lannett Selling Generic Bactrim 09.14.05 | 01:09 pm
Press Releases for LCI
- Lannett Reports Fiscal 2012 Second Quarter Financial Results - Business Wire 02.07.12 | 04:02 pm
- Lannett Receives FDA Approval For ANDA Supplement For Phentermine HCL Capsules, 15 Mg - Business Wire 01.31.12 | 08:01 am
- Lannett To Report Fiscal 2012 Second-Quarter Financial Results And Host Conference Call On Tuesday, February 7 - Business Wire 01.30.12 | 03:01 pm
- Lannett Receives FDA Approval For Hydrochlorothiazide Capsules, 12.5 Mg - Business Wire 01.30.12 | 08:01 am
- Lannett Receives Letter From NYSE Amex Regarding Timely Notice Of Record Date For 2012 Annual Shareholders Meeting - Business Wire 01.06.12 | 04:01 pm
- Lannett Reaches Special Protocol Assessment Agreement With FDA For Cocaine HCl Phase III Trial - Business Wire 01.04.12 | 11:01 am
- Lannett Receives FDA Approval For Triamterene With Hydrochlorothiazide 37.5/25mg Capsules - Business Wire 12.12.11 | 02:12 pm
- Lannett To Present At Oppenheimer 22nd Annual Healthcare Conference On December 14th - Business Wire 12.07.11 | 08:12 am
- Lannett To Present At Lazard Capital Markets 8th Annual Healthcare Conference On November 15th - Business Wire 11.10.11 | 11:11 am
- Lannett Reports Improved Results For Fiscal 2012 First Quarter - Business Wire 11.03.11 | 04:11 pm
Partner Headlines for LCI
- Lannett Receives Letter from NYSE Amex Regarding Timely Notice of Record Date for 2012 Annual Shareholders Meeting - Benzinga 01.06.12 | 04:01 pm
- Lannett Receives FDA Approval for Diethylpropion HCl Extended Release Tablets, 75 mg - Benzinga 10.24.11 | 01:10 pm
- Mylan Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue - Benzinga 10.21.11 | 04:10 pm
- Lannett Receives FDA Approval for Morphine Sulfate Oral Solution NDA - Benzinga 06.24.11 | 09:06 am
- Life Sciences Companies Raise Record Amounts of Capital - Seeking Alpha 12.31.10 | 04:12 pm
- BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011 - Seeking Alpha 12.28.10 | 03:12 am
- Lannett Reports Stronger 4Q Earnings Despite Revenue Drop - Fox Business 09.13.10 | 03:09 pm
- Why You Should Diversify With U.S. Stocks - Seeking Alpha 05.13.10 | 01:05 pm
